Show simple item record

dc.contributor.authorMartínez Carrasco, Alejandro
dc.contributor.authorReal, Raquel
dc.contributor.authorLawton, Michael
dc.contributor.authorIwaki, H
dc.contributor.authorTan, Manuela
dc.contributor.authorWu, L
dc.contributor.authorWilliams, Nigel
dc.contributor.authorCarroll, Camille
dc.contributor.authorHu, MTM
dc.contributor.authorGrosset, DG
dc.contributor.authorHardy, J
dc.contributor.authorRyten, Mina
dc.contributor.authorKhotian, Artem
dc.contributor.authorBen-Shlomo, Y
dc.contributor.authorShoai, M
dc.contributor.authorMorris, Huw
dc.date.accessioned2023-11-08T11:36:29Z
dc.date.available2023-11-08T11:36:29Z
dc.date.issued2023-08-31
dc.identifier.issn2373-8057
dc.identifier.issn2373-8057
dc.identifier.other128
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/21617
dc.description.abstract

<jats:title>Abstract</jats:title><jats:p>The genetic basis of levodopa-induced-dyskinesia (LiD) is poorly understood, and there have been few well-powered genome-wide studies. We performed a genome-wide survival meta-analyses to study the effect of genetic variation on the development of LiD in five separate longitudinal cohorts, and meta-analysed the results. We included 2784 PD patients, of whom 14.6% developed LiD. We found female sex (HR = 1.35, SE = 0.11, <jats:italic>P</jats:italic> = 0.007) and younger age at onset (HR = 1.8, SE = 0.14, <jats:italic>P</jats:italic> = 2 × 10<jats:sup>−5</jats:sup>) increased the probability of developing LiD. We identified three genetic loci significantly associated with time-to-LiD onset. <jats:bold>rs72673189</jats:bold> on chromosome 1 (HR = 2.77, SE = 0.18, <jats:italic>P</jats:italic> = 1.53 × 10<jats:sup>−8</jats:sup>) located at the LRP8 locus, <jats:bold>rs189093213 on</jats:bold> chromosome 4 (HR = 3.06, SE = 0.19, <jats:italic>P</jats:italic> = 2.81 × 10<jats:sup>−9</jats:sup>) in the non-coding RNA <jats:italic>LINC02353</jats:italic> locus, and <jats:bold>rs180924818</jats:bold> on chromosome 16 (HR = 3.13, SE = 0.20, <jats:italic>P</jats:italic> = 6.27 × 10<jats:sup>−9</jats:sup>) in the <jats:italic>XYLT1</jats:italic> locus. Based on a functional annotation analysis on chromosome 1, we determined that changes in DNAJB4 gene expression, close to LRP8, are an additional potential cause of increased susceptibility to LiD. Baseline anxiety status was significantly associated with LiD (OR = 1.14, SE = 0.03, <jats:italic>P</jats:italic> = 7.4 × 10<jats:sup>−5</jats:sup>). Finally, we performed a candidate variant analysis of previously reported loci, and found that genetic variability in <jats:italic>ANKK1</jats:italic> (<jats:italic>rs1800497</jats:italic>, HR = 1.27, SE = 0.09, <jats:italic>P</jats:italic> = 8.89 × 10<jats:sup>−3</jats:sup>) and <jats:italic>BDNF</jats:italic> (<jats:italic>rs6265</jats:italic>, HR = 1.21, SE = 0.10, <jats:italic>P</jats:italic> = 4.95 × 10<jats:sup>−2</jats:sup>) loci were significantly associated with time to LiD in our large meta-analysis.</jats:p>

dc.format.extent128-
dc.format.mediumElectronic
dc.languageen
dc.publisherSpringer Science and Business Media LLC
dc.subjectBrain Disorders
dc.subjectPrevention
dc.subjectHuman Genome
dc.subjectGenetics
dc.titleGenetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001055619900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue1
plymouth.volume9
plymouth.publication-statusPublished online
plymouth.journalnpj Parkinson's Disease
dc.identifier.doi10.1038/s41531-023-00573-2
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CCT&PS
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
plymouth.organisational-group|Plymouth|Research Groups|FoH - Community and Primary Care
plymouth.organisational-group|Plymouth|Research Groups|FoH - Applied Parkinson's Research
plymouth.organisational-group|Plymouth|Research Groups|Plymouth Institute of Health and Care Research (PIHR)
dc.publisher.placeUnited States
dcterms.dateAccepted2023-08-16
dc.date.updated2023-11-08T11:35:47Z
dc.identifier.eissn2373-8057
rioxxterms.versionofrecord10.1038/s41531-023-00573-2


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV